Home  »  Industry   »  Market data suggests positive returns on Mereo Bio...

Market data suggests positive returns on Mereo BioPharma Group plc (MREO)

At the end of the latest market close, Mereo BioPharma Group plc (MREO) was valued at $0.84. In that particular session, Stock kicked-off at the price of $0.8439 while reaching the peak value of $1.00 and lowest value recorded on the day was $0.801. The stock current value is $0.97.

Mereo BioPharma Group plc had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.0200 on 01/17/23, with the lowest value was $0.6100 for the same time period, recorded on 01/04/23.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Mereo BioPharma Group plc (MREO) full year performance was -23.02%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Mereo BioPharma Group plc shares are logging -47.57% during the 52-week period from high price, and 222.26% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.30 and $1.85.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1427330 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Mereo BioPharma Group plc (MREO) recorded performance in the market was 29.33%, having the revenues showcasing 0.36% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 121.24M, as it employees total of 49 workers.

The Analysts eye on Mereo BioPharma Group plc (MREO)

During the last month, 0 analysts gave the Mereo BioPharma Group plc a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.8721, with a change in the price was noted -0.35. In a similar fashion, Mereo BioPharma Group plc posted a movement of -26.52% for the period of last 100 days, recording 593,237 in trading volumes.

Technical rundown of Mereo BioPharma Group plc (MREO)

Raw Stochastic average of Mereo BioPharma Group plc in the period of last 50 days is set at 90.49%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 90.49%. In the last 20 days, the company’s Stochastic %K was 75.59% and its Stochastic %D was recorded 75.37%.

Considering, the past performance of Mereo BioPharma Group plc, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 29.33%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -38.99%, alongside a downfall of -23.02% for the period of the last 12 months. The shares increased approximately by 9.38% in the 7-day charts and went down by 69.28% in the period of the last 30 days. Common stock shares were driven by 0.36% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts